| Biologic Therapy |
1 |
1 |
| Platelet Count |
0 |
0.9 |
| Platelet Reactivity |
0 |
0.75 |
| Platelet Transfusion |
0 |
0.61 |
| Hypertension |
0 |
0.39 |
| Myocardial Infarction (MI) |
0 |
0.39 |
| Monoclonal Antibody |
0 |
0.99 |
| Food and Drug Administration (FDA) |
0 |
0.16 |
| Hemorrhage |
0 |
0.16 |
| Brachial |
0 |
0.08 |
| Europe |
0 |
0.08 |
| Heart |
0 |
0.08 |
| Myocardial Infarction (MI) History |
0 |
0.08 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.08 |
| Receptors |
0 |
0.08 |
| Surgery |
0 |
0.08 |
| Transfusion |
0 |
0.08 |